Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012

Authors

  • Deepika Mahajan National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, Australia
  • Jane Cook Office of Product Review, Therapeutic Goods Administration, Canberra, Australia
  • Aditi Dey National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, Australia
  • Kristine Macartney National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, Australia
  • Rob Menzies National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, Australia

DOI:

https://doi.org/10.33321/cdi.2013.37.18

Keywords:

AEFI, surveillance, immunisation, vaccine safety

Abstract

This report summarises national passive surveillance data reported to the Therapeutic Goods Administration (TGA) to 31 August 2012 for adverse events following immunisation (AEFI) for children aged <7 years who received vaccines between 1 January and 30 June 2012.

Downloads

Download data is not yet available.

References

National Health and Medical Research Council. The Australian Immunisation Handbook. 9th edn. Canberra: Australian Government Department of Health, 2008.

Australian Government Department of Health. Immunise Australia program. Pneumococcal Disease: Recent changes to pneumococcal vaccine for children Program providing a supplementary dose of Prevenar 13®. [Internet] Available from: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-pneumococcal Accessed on 16th August 2012.

Northern Territory Government, Department of Health. NT Immunisation Schedule. [Internet] Available from: http://www.health.nt.gov.au/library/scripts/objectifyMedia.aspxfile=pdf/10/78.pdf&siteID=1&str_title=Childhood Vaccination Schedule.pdf Accessed on 16th August 2012.

Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, et al. Surveillance of adverse events following immunisation: Australia, 2000-2002. Commun Dis Intell 2003;27:307-323.

Mahajan D, Cook J, Mclntyre P, Macartney K, Menzies R. Supplementary report: surveillance of adverse events following immunisation among children aged <7 years in Australia, 1 January to 30 June 2011. Commun Dis Intell 2012;36(1):114-119.

Mahajan D, Menzies R, Cook J, Macartney K, McIntyre P. Supplementary report: surveillance of adverse events following immunisation among children aged <7 years in Australia, 1 January to 30 June 2010. Commun Dis Intell 2011;35(1):18-25.

Mahajan D, Menzies R, Roomiani I, Lawrence GL. Supplementary report: surveillance of adverse events fol¬lowing immunisation among children aged < 7 years in Australia, 1 January to 30 June 2009. Commun Dis Intell 2010;34(1):49–53.

Mahajan D, Roomiani I, Gold M, Lawrence G, McIntyre P, Menzies R. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Commun Dis Intell 2010;34(3):259–276.

Menzies R, Mahajan D, Gold MS, Roomiani I, McIntyre P, Lawrence G. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Commun Dis Intell 2009;33(4):365–381.

Australian Government Department of Health, Therapeutic Goods Administration. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination. Status report as at 2 July 2010 (updated 24 September 2010). [Internet] Available from: http://www.tga.gov.au/ safety/alerts-medicine-seasonal-flu-100702.htm

Australian Government Department of Health, TGA. Australian Public Assessment Report for Pneumococcal Polysaccharide Conjugate Vaccine (Prevenar 13®). [Internet] Available from: http://www.tga.gov.au/pdf/auspar/auspar-prevenar13.pdf Accessed on 16th August 2012.

Simon L S. Pharmacovigilance: towards a better understanding of the benefit to risk ratio. Ann Rheum Dis 2002;61(Suppl II):ii88–ii89.

Supplementary report: surveillance of adverse events following immunisation among children.

Downloads

Published

01/06/13

How to Cite

Mahajan, Deepika, Jane Cook, Aditi Dey, Kristine Macartney, and Rob Menzies. 2013. “Supplementary Report: Surveillance of Adverse Events Following Immunisation Among Children Aged Less Than Seven Years in Australia, 1 January to 30 June 2012”. Communicable Diseases Intelligence 37 (June):130-35. https://doi.org/10.33321/cdi.2013.37.18.

Issue

Vol. 37 (2013)

Section

Annual report

Categories

License

Copyright (c) 2013 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 > >>